RPRX
Royalty Pharma plc · Healthcare · Medical - Pharmaceuticals
Input momentum (manajer yang sebanding):
keluasan pemegang -7.1% ·
aliran saham +7.1% ·
posisi baru bersih -7.7%
— formula
Akumulasi terkonsentrasi — peningkatan saham di antara lebih sedikit pemegang
Semua angka kepemilikan: hanya manajer 13F yang dipantau, posisi saham biasa, periode pelaporan Q3 2024
| Kuartal | Pemegang | Δ | Saham | Nilai yang dilaporkan | Baru | Keluar |
|---|---|---|---|---|---|---|
| Q2 2026 | 146 | 0 | 306.62M | $17.19B | +5 | −4 |
| Q1 2026 | 148 | +6 | 297.67M | $14.26B | +10 | −5 |
| Q4 2025 | 141 | +1 | 305.31M | $11.80B | +2 | — |
| Q3 2025 | 19 | +1 | 173.40M | $6.12B | +2 | −2 |
| Q2 2025 | 16 | 0 | 158.26M | $5.71B | — | — |
| Q1 2025 | 13 | -3 | 61.13M | $1.91B | — | −3 |
| Q4 2024 | 16 | +2 | 77.30M | $1.97B | +2 | — |
| Q3 2024 | 13 | -1 | 62.78M | $1.78B | +1 | −2 |
| Q2 2024 | 14 | — | 58.59M | $1.54B | — | — |
| # | Manajer | Saham | Δ saham | Nilai | Bobotnya | Dipegang | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Baillie Gifford ✦ | 16.12M | -1.4% | $456.11M | 0.3% | ▼ Trim | 2 | SEC ↗ |
| 2 | Baillie Gifford ✦ | 16.12M | -1.4% | $456.11M | 0.3% | ▼ Trim | 2 | SEC ↗ |
| 3 | Baillie Gifford ✦ | 16.12M | -1.4% | $456.11M | 0.3% | ▼ Trim | 2 | SEC ↗ |
| 4 | Baillie Gifford ✦ | 16.12M | -1.4% | $456.11M | 0.3% | ▼ Trim | 2 | SEC ↗ |
| 5 | Viking Global Investors ✦ | 12.09M | +1.0% | $342.14M | 1.2% | ▲ Add | 2 | SEC ↗ |
| 6 | Adage Capital Partners ✦ | 11.90M | +8.8% | $336.63M | 0.6% | ▲ Add | 2 | SEC ↗ |
| 7 | Geode Capital Management ✦ (pasif) | 7.27M | +6.1% | $205.56M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 8 | Geode Capital Management ✦ (pasif) | 7.27M | +6.1% | $205.56M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 9 | Norges Bank ✦ (pasif) | 4.81M | 0.0% | $136.06M | 0.0% | Held | 2 | SEC ↗ |
| 10 | Millennium Management ✦ | 4.34M | +84.7% | $122.82M | 0.1% | ▲ Add | 2 | SEC ↗ |
| 11 | Two Sigma Investments ✦ | 2.43M | +18.1% | $68.73M | 0.2% | ▲ Add | 2 | SEC ↗ |
| 12 | Arrowstreet Capital ✦ | 1.39M | +47.9% | $39.33M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 13 | D. E. Shaw & Co. ✦ | 932.34K | +2673.8% | $26.38M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 14 | AQR Capital Management ✦ | 663.29K | -15.6% | $18.71M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 15 | AQR Capital Management ✦ | 663.29K | -15.6% | $18.71M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 16 | AQR Capital Management ✦ | 663.29K | -15.6% | $18.71M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 17 | Point72 Asset Management ✦ | 526.63K | Baru | $14.90M | 0.1% | New | 1 | SEC ↗ |
| 18 | T. Rowe Price ✦ | 286.30K | +5.9% | $8.10M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 19 | Wellington Management ✦ | 17.81K | -69.0% | $503,732 | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 20 | Wellington Management ✦ | 17.81K | -69.0% | $503,732 | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 21 | Wellington Management ✦ | 17.81K | -69.0% | $503,732 | 0.0% | ▼ Trim | 2 | SEC ↗ |
"Bobot mereka" = porsi posisi dari total nilai ekuitas 13F yang dilaporkan manajer tersebut — ukuran keyakinan. ✦ = manajer yang dikurasi.
Pembeli baru
| Point72 Asset Management | $14.90M | 0.1% |
Telah keluar
| Marshall Wace | $24.94M | adalah 0.0% |
| Bridgewater Associates | $6.30M | adalah 0.0% |
Konteks pasar penuh: di SEMUA filer 13F (data terstruktur SEC, Q1 2026): 583 pemegang, 354.58M saham, $16.55B dilaporkan. Ini adalah periode berbeda yang lebih lama dibandingkan angka semesta yang dilacak di atas, dan keduanya tidak pernah dicampur.
Apa lagi yang paling sering dimiliki oleh pemegang efek ini yang dilacak — berdasarkan jumlah kepemilikan bersama, bukan hubungan fundamental.
Pembelian di pasar terbuka (P)
Tidak ada pembelian insider di pasar terbuka dalam jendela cakupan kami.
Penjualan di pasar terbuka (S)
Officer · 100.00K lbr · $6.00M
Officer · 9.23K lbr · $540,752
Officer · 1.77K lbr · $104,799
Penghargaan, eksekusi, dan pemotongan pajak tidak pernah dihitung sebagai pembelian atau penjualan di sini. Metodologi
18.7% dari kelas · Lihat pengajuan SEC asli ↗
4.8% dari kelas · Lihat pengajuan SEC asli ↗